Brian Delaney serves as the Director of Global Transparency at AbbVie, where he leverages his extensive experience in change management and international operations to drive strategic initiatives that enhance compliance and transparency across the pharmaceutical landscape. With a robust background in supporting Fortune 200 companies,...
Brian Delaney serves as the Director of Global Transparency at AbbVie, where he leverages his extensive experience in change management and international operations to drive strategic initiatives that enhance compliance and transparency across the pharmaceutical landscape. With a robust background in supporting Fortune 200 companies, Brian is adept at navigating the complexities of global supply chain operations and back-office functions. His current role involves the development and execution of comprehensive global strategies that ensure the accurate capture, verification, and disclosure of Healthcare Professional (HCP) and Healthcare Organization (HCO) transfers of value (ToVs) in compliance with regulations across more than 40 countries.
Brian's leadership is pivotal in coordinating resources—including personnel, processes, and technology—to streamline operations and improve efficiencies within AbbVie’s global functions and third-party affiliates. His expertise in software project management and IT management has been instrumental in the successful implementation of SAP systems, which have significantly enhanced data integrity and operational transparency. Additionally, Brian's proficiency in regulatory frameworks, such as 21 CFR Part 11, positions him as a key player in ensuring that AbbVie meets stringent compliance standards while fostering a culture of accountability and ethical business practices.
As a change-focused leader, Brian is committed to continuous improvement and innovation, driving initiatives that not only meet regulatory requirements but also enhance the overall integrity of the organization. His ability to manage complex projects and lead cross-functional teams makes him a vital asset to AbbVie as it navigates the evolving landscape of global healthcare regulations.
